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Prevalence of etravirine (ETR)-RAMs at NNRTI failure and predictors of resistance to ETR in
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Abstract
The prevalence of drug resistance associated with the failure of non-nucleoside reverse transcriptase inhibitor (NNRTI)-based regimens and
the predictors of resistance to Etravirine (ETR) were assessed in 2854 subjects: 39 < 18 (paediatric) and 2815 ≥ 18 (adult) years old. These
subjects failed to respond to their current NNRTI treatment, were three-class experienced and had been exposed to NNRTI for
≥3 months. A total of 1827 adult (64.9%) and 32 paediatric subjects (82.1%) harboured the virus with at least one ETR mutation. V179I,
Y181C and G190A were the most frequent mutations in both groups. A signiﬁcantly increased risk of ETR resistance with all three
algorithms (Monogram (MGR) >3, Tibotec (TBT) >2 and enhanced MGR (ENH) ≥4) emerged in the paediatric population. Multivariate
analysis revealed an increased risk of developing TBT >2 for NNRTI exposure, ENH ≥4 for NNRTI and EFV exposure in paediatric subjects;
NVP exposure and higher (≥3.5 log10) HIV-RNA values for all three algorithms in adult subjects, whereas CD4 ≥ 200/lL appeared to be
protective. The risk of being ETR resistant was more than doubled for paediatric vs. adult subjects, probably due to a more extensive use of
NNRTI and an incomplete virological control.
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Abstract
The aim of this work was to assess the value of the physical status of human papillomavirus (HPV) DNA as a disease marker for cervical
cancer development in a set of 248 DNA samples previously genotyped as HPV 16 or 18, by calculating the E2/E6 ratio through real-time
PCR. There was a signiﬁcant difference in integration status according to disease grade for both genotypes (p <0.001). Furthermore,
especially for HPV 18, determining the DNA physical status could be a useful biomarker in predicting cervical cancer risk development, with
a lower E2/E6 ratio clinically associated with the development of a precancerous lesion.
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Abstract
Neutralizing antibodies against West Nile (WNV) and Usutu (USUV) viruses were measured in 6000 samples collected, between 1
September 2010 and 30 June 2011, from blood donors living in different districts of Emilia-Romagna, northeastern Italy. On the basis of the
microneutralization assay (MNTA), 47 (0.78%) subjects were positive for WNV and 14 (0.23%) for USUV. These results were compared
with those obtained 2 years ago and suggest an increased circulation of USUV among humans in Emilia-Romagna.
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Abstract
Human immunodeﬁciency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV) are major public health concerns. We aimed to
determine the prevalence of HBV and HCV infections among HIV-infected patients, and to identify the main circulating hepatitis strains in
Morocco. The study was carried out in 503 HIV-infected patients. Our survey indicated that the prevalence of HIV/hepatitis co-infection
was 10.6%; 5.2% of patients were HBV surface antigen positive, and 5.4% of patients were anti-HCV positive. Among the HBV surface
antigen-positive group, HBV DNA sequencing identiﬁed exclusively genotype D (D1: 26.7%; D7: 73.3%) in accordance with what is found in
the general population. In contrast, sequencing of HCV isolates produced an unusual subtype distribution with a decreasing order of
prevalence: 1a, 3a (both 23.5%), 1b, 4a (both 17.6%), 1c (11.8%) and 6h (6%).
ª2013 The Authors
Clinical Microbiology and Infection ª2013 European Society of Clinical Microbiology and Infectious Diseases, CMI, 19, 945–947
CMI Online-Only Abstracts 947
